{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:38:43Z","timestamp":1793129923457,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ80154"],"award-info":[{"award-number":["2025JJ80154"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ40076"],"award-info":[{"award-number":["2025JJ40076"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404433"],"award-info":[{"award-number":["82404433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400506"],"award-info":[{"award-number":["82400506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104833","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:46:11Z","timestamp":1791848771000},"page":"104833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role and mechanism of heat shock proteins in the development of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"31","author":[{"given":"Honglin","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-488X","authenticated-orcid":false,"given":"Liqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104833_b0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chest.2018.11.030","article-title":"Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report","volume":"155","author":"Klinger","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.drudis.2026.104833_b0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0025","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/diagnostics14182052","article-title":"Diagnosis and management of pulmonary hypertension: new insights","volume":"14","author":"Ntiloudi","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.drudis.2026.104833_b0030","doi-asserted-by":"crossref","first-page":"15153","DOI":"10.1021\/acs.jmedchem.0c01093","article-title":"Targeted drugs for treatment of pulmonary arterial hypertension: past, present, and future perspectives","volume":"63","author":"Zheng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0035","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.14336\/AD.2020.0111","article-title":"Pathological mechanisms and potential therapeutic targets of pulmonary arterial hypertension: a review","volume":"11","author":"Xiao","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.drudis.2026.104833_b0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01095-2024","article-title":"Pathology and pathobiology of pulmonary hypertension: current insights and future directions","volume":"64","author":"Guignabert","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0045","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0093-2017","article-title":"Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled","volume":"26","author":"Hemnes","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.drudis.2026.104833_b0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmed.2016.11.005","article-title":"Targeting vascular remodeling to treat pulmonary arterial hypertension","volume":"23","author":"Thompson","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2026.104833_b0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cvr\/cvz308","article-title":"Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator","volume":"116","author":"Huertas","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.drudis.2026.104833_b0065","doi-asserted-by":"crossref","first-page":"12858","DOI":"10.3390\/ijms252312858","article-title":"Searching for old and new small-molecule protein kinase inhibitors as effective treatments in pulmonary hypertension \u2013 a systematic review","volume":"25","author":"Jasi\u0144ska-Stroschein","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104833_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1283233","article-title":"Pulmonary hypertension and insulin resistance: a mechanistic overview","volume":"14","author":"Zanotto","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.drudis.2026.104833_b0075","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/09031936.00126010","article-title":"Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"37","author":"Dumitrascu","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.drudis.2026.104833_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020971954","article-title":"Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study","volume":"10","author":"Sodimu","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.drudis.2026.104833_b0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/clpt.2009.217","article-title":"A dosing\/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension","volume":"87","author":"Gomberg-Maitland","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104833_b0090","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.drudis.2026.104833_b0095","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3390\/antiox12111978","article-title":"Unleashing the potential of Nrf2: a novel therapeutic target for pulmonary vascular remodeling","volume":"12","author":"Fang","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.drudis.2026.104833_b0100","doi-asserted-by":"crossref","first-page":"41605","DOI":"10.1038\/srep41605","article-title":"Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways","volume":"7","author":"Grzegorzewska","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104833_b0105","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.2009.00445.x","article-title":"Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension","volume":"158","author":"Agard","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2026.104833_b0110","doi-asserted-by":"crossref","first-page":"L262","DOI":"10.1152\/ajplung.00389.2014","article-title":"Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response","volume":"309","author":"Chen","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.drudis.2026.104833_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-12-141","article-title":"VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension","volume":"12","author":"Hamidi","year":"2011","journal-title":"Resp Res"},{"key":"10.1016\/j.drudis.2026.104833_b0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/medicina59040748","article-title":"Prognostic value for mortality of plasma bioactive adrenomedullin in patients with pulmonary arterial hypertension: a sub analysis of the biomarker study in the COHARD-PH registry","volume":"59","author":"Hartopo","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.drudis.2026.104833_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40256-024-00694-w","article-title":"Sotatercept: the first FDA-approved activin A receptor IIA inhibitor used in the management of pulmonary arterial hypertension","volume":"25","author":"Villanueva","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.drudis.2026.104833_b0130","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00204-021-03070-8","article-title":"The functions and regulation of heat shock proteins; key orchestrators of proteostasis and the heat shock response","volume":"95","author":"Lang","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.drudis.2026.104833_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biopha.2018.02.037","article-title":"Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104833_b0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12931-022-02124-4","article-title":"Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP\/TAZ-TEAD4 pathway","volume":"23","author":"Liu","year":"2022","journal-title":"Resp Res"},{"key":"10.1016\/j.drudis.2026.104833_b0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.12965\/jer.1632642.321","article-title":"Size dependent classification of heat shock proteins: a mini-review","volume":"12","author":"Jee","year":"2016","journal-title":"J Exerc Rehabil"},{"key":"10.1016\/j.drudis.2026.104833_b0150","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/cancers16081500","article-title":"Heat shock proteins, a double-edged sword: significance in cancer progression, chemotherapy resistance and novel therapeutic perspectives","volume":"16","author":"Kunachowicz","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104833_b0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-025-02166-2","article-title":"Advances in the structures, mechanisms and targeting of molecular chaperones","volume":"10","author":"Gu","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.drudis.2026.104833_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116633","article-title":"Exploring heat shock proteins as therapeutic targets for Parkinson\u2019s disease","volume":"230","author":"Li","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104833_b0165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/cancers16030638","article-title":"The interplay between heat shock proteins and cancer pathogenesis: a novel strategy for cancer therapeutics","volume":"16","author":"Somu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2026.104833_b0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.molcel.2017.12.003","article-title":"Molecular mechanism of J-domain-triggered ATP hydrolysis by Hsp70 chaperones","volume":"69","author":"Kityk","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2026.104833_b0175","doi-asserted-by":"crossref","first-page":"L351","DOI":"10.1152\/ajplung.00264.2013","article-title":"Inducible HSP70 regulates superoxide dismutase-2 and mitochondrial oxidative stress in the endothelial cells from developing lungs","volume":"306","author":"Afolayan","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.drudis.2026.104833_b0180","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1021\/jm100342z","article-title":"ATPases as drug targets: insights from heat shock proteins 70 and 90","volume":"53","author":"Massey","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0185","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1021\/acs.jmedchem.0c02091","article-title":"Function, therapeutic potential, and inhibition of Hsp70 chaperones","volume":"64","author":"Ambrose","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0190","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034017","article-title":"Structure, function, and regulation of the Hsp90 machinery","volume":"11","author":"Biebl","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.drudis.2026.104833_b0195","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nsmb.2502","article-title":"Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle","volume":"20","author":"Li","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2026.104833_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201708-1751OC","article-title":"Mitochondrial Hsp90 accumulation promotes vascular remodeling in pulmonary arterial hypertension","volume":"198","author":"Boucherat","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.drudis.2026.104833_b0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fphys.2020.01081","article-title":"New insights into heat shock protein 90 in the pathogenesis of pulmonary arterial hypertension","volume":"11","author":"Hu","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.drudis.2026.104833_b0210","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1074\/jbc.RA119.009016","article-title":"Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism","volume":"294","author":"Dai","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.febslet.2007.12.025","article-title":"Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase","volume":"582","author":"Nedvetsky","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.drudis.2026.104833_b0220","doi-asserted-by":"crossref","first-page":"H260","DOI":"10.1152\/ajpheart.01027.2005","article-title":"Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation","volume":"291","author":"Yetik-Anacak","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.drudis.2026.104833_b0225","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1074\/jbc.M114.559393","article-title":"Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content","volume":"289","author":"Ghosh","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0230","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acs.jmedchem.4c01364","article-title":"Discovery and optimization of Hsp110 and sGC dual-target regulators for the treatment of pulmonary arterial hypertension","volume":"67","author":"Hu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0235","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104833_b0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.drudis.2018.12.001","article-title":"TGF\u03b2 and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension","volume":"24","author":"Tielemans","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104833_b0245","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1073\/pnas.0800163105","article-title":"Critical regulation of TGFbeta signaling by Hsp90","volume":"105","author":"Wrightont","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2026.104833_b0250","doi-asserted-by":"crossref","first-page":"54263","DOI":"10.18632\/oncotarget.10855","article-title":"Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104833_b0255","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/cells14241989","article-title":"Targeting Hsp90 in cancer for 25 years: failure of previous clinical trials and new hope for future therapeutics","volume":"14","author":"Chen","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104833_b0260","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/cells11060976","article-title":"Hsp90 in human diseases: molecular mechanisms to therapeutic approaches","volume":"11","author":"Sumi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104833_b0265","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/cells10020254","article-title":"The role of non-canonical Hsp70s (Hsp110\/Grp170) in cancer","volume":"10","author":"Chakafana","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104833_b0270","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/s41467-023-38220-2","article-title":"A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi","volume":"14","author":"Hu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104833_b0275","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1074\/jbc.M111.275057","article-title":"Unique peptide substrate binding properties of 110-kDa heat-shock protein (Hsp110) determine its distinct chaperone activity","volume":"287","author":"Xu","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104199","article-title":"Heat shock protein 110: a novel candidate for disease diagnosis and targeted therapy","volume":"29","author":"Zhao","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104833_b0285","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12931-023-02600-5","article-title":"Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model","volume":"24","author":"Zhao","year":"2023","journal-title":"Resp Res"},{"key":"10.1016\/j.drudis.2026.104833_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107888","article-title":"Design, synthesis and optimization of pyrazolo[3,4-b] pyridine derivatives as Hsp110-STAT3 interaction disruptors for the treatment of pulmonary arterial hypertension","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2026.104833_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116855","article-title":"Allosteric site identification, virtual screening and discovery of a sulfonamide Hsp110-STAT3 interaction inhibitor for the treatment of hypoxic pulmonary arterial hypertension","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur J Med Chem"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:21:04Z","timestamp":1793128864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002382"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104833","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and mechanism of heat shock proteins in the development of pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104833"}}